INDIAN JOURNAL OF CHEMISTRY, published by the NATL INST SCIENCE COMMUNICATION & POLICY RESEARCH (NIScPR), stands as a vital platform for disseminating innovative research and advancements in the fields of organic, inorganic, and physical chemistry. With its inception in 1969, this journal has served the global community of chemists and researchers, contributing significantly to the advancement of chemical sciences in India and beyond. The journal maintains a strong commitment to open access, facilitating widespread dissemination of knowledge, allowing readers from diverse backgrounds to access cutting-edge research without barriers. Although coverage in Scopus has been temporarily discontinued, the journal continues to uphold rigorous scholarly standards, making it an authoritative source for academicians, professionals, and students alike. Readers can expect high-quality articles that reflect the latest developments and discoveries in chemistry, reinforcing the journal's reputation as an essential resource in the scientific community.

Heterocyclic Letters is an esteemed journal in the field of synthetic organic chemistry, published by RAMAN PUBL. With ISSN 2231-3087 and E-ISSN 2230-9632, this journal aims to disseminate original research and innovative findings related to heterocyclic compounds, which play a crucial role in medicinal chemistry, material science, and agricultural chemistry. Heterocyclic Letters provides a platform for researchers, professionals, and students to share their insights and advancements, thus fostering academic collaboration and knowledge transfer. The journal is dedicated to maintaining high-quality standards in research publication, making it an essential resource for anyone focused on the latest developments in heterocyclic chemistry. Although it does not currently offer Open Access options, the journal’s rigorous peer-review process ensures that only the most credible and impactful studies are published, contributing significantly to the advancement of the field.

CURRENT PROTEIN & PEPTIDE SCIENCE, published by Bentham Science Publishers, is a pivotal journal dedicated to the dynamic and rapidly evolving fields of protein and peptide research. With an ISSN of 1389-2037 and an E-ISSN of 1875-5550, this esteemed journal serves as a platform for disseminating cutting-edge findings from various disciplines, including biochemistry, cell biology, and molecular biology. Recognized for its influence with a 2023 Scopus ranking placing it within the top quartiles of its categories—Q3 in Biochemistry, Q4 in Cell Biology, and Q2 in Medicine—the journal not only enhances the visibility of critical research but also supports the academic community in advancing our understanding of the molecular foundations of life. Established in 2000 and running through 2024, CURRENT PROTEIN & PEPTIDE SCIENCE is positioned to cater to the interests of researchers, professionals, and students alike, providing them with open access to vital knowledge that fuels innovation and scientific inquiry in the United Arab Emirates and beyond.

JOURNAL OF THE CHINESE CHEMICAL SOCIETY, published by WILEY-V C H VERLAG GMBH, is a vital resource in the field of chemistry, focusing on a broad array of topics pertinent to general chemistry and its advancing sub-disciplines. Established in 1954 and running through 2024, this journal serves as a significant platform for the dissemination of high-quality research, showcasing innovative findings and developments within the chemical sciences. With its Q3 category ranking and positioning at Rank #203 in General Chemistry per Scopus, it reflects the journal's commitment to research excellence and impact. While not an open-access publication, it ensures accessibility to a global audience, making it an essential tool for researchers, professionals, and students alike seeking to stay informed and engaged in the evolving landscape of chemistry.

PEPTIDES, published by Elsevier Science Inc, is a premier journal in the field of Biochemistry that has made a significant impact since its inception in 1980. With a current Impact Factor that places it in the Q2 and Q3 quartiles across multiple categories—including Cellular and Molecular Neuroscience and Endocrinology—this journal serves as a vital resource for researchers and professionals seeking to advance their understanding of peptide biology and its broad implications in health and disease. The journal's Scopus ranking reflects its relevance and esteemed contributions, ranking in the top percentiles in various biological disciplines. While currently not available as an open-access option, the depth of peer-reviewed research articles, reviews, and communications offered aims to push the boundaries of knowledge in physiology and molecular biology. As it converges towards 2024, PEPTIDES continues to be a beacon for innovative research that inspires the next generation of scientists.

The Journal of Saudi Chemical Society, published by ELSEVIER, stands as a premier platform for advancing knowledge in the field of chemistry. Since its inception in 2009, this Open Access journal has garnered significant attention, securing a prestigious Q1 ranking in the Chemistry (miscellaneous) category for 2023, reflecting its position among the top journals in the discipline. With an impressive Scopus ranking of #66 out of 408 in General Chemistry, this journal boasts a commendable 83rd percentile, underscoring its impact and relevance in the global research community. The journal aims to disseminate high-quality research articles, reviews, and case studies, fostering innovation and collaboration among chemists and allied professionals. By enabling widespread access to cutting-edge research, the Journal of Saudi Chemical Society plays a crucial role in supporting the educational and professional development of students, researchers, and practitioners alike, making it an essential resource for anyone invested in the dynamic field of chemistry.

ACS Bio & Med Chem Au, published by the esteemed American Chemical Society, stands at the forefront of interdisciplinary research within the realms of biochemistry, drug discovery, pharmaceutical sciences, and molecular biology. With an impressive Impact Factor indicative of its rigorous academic standards and significant contributions to the field, this open-access journal is committed to disseminating high-quality research that drives innovation and advancements in biosciences and medicinal chemistry. Since its inception in 2021, the journal has rapidly earned recognition, achieving a commendable Q1 ranking in multiple categories, including Biochemistry, Drug Discovery, and Pharmaceutical Science, while also making strides in Molecular Biology. Researchers, professionals, and students alike can explore pioneering studies that bridge gaps between laboratory research and clinical applications, fostering collaborative efforts towards novel therapeutic strategies. With a focus on enhancing accessibility and engagement within the scientific community, ACS Bio & Med Chem Au is poised to impact the future of biomedical research significantly.

PROTEIN AND PEPTIDE LETTERS is a prominent peer-reviewed journal published by Bentham Science Publishers Ltd, specializing in the dynamic fields of biochemistry and structural biology. With an ISSN of 0929-8665 and a corresponding E-ISSN of 1875-5305, the journal has been a pivotal platform for researchers since its inception in 1994. Spanning various aspects of protein and peptide research, it aims to disseminate groundbreaking findings that enhance our understanding of molecular mechanisms and therapeutic applications. Although categorized in the Q3 quartile for biochemistry and medicine, and Q4 in structural biology within the 2023 metrics, it remains a valuable resource in the academic arena, offering insight into the latest research and advancements. As the journal converges towards its 2024 milestone, it continues to reflect the evolving landscape of molecular research. While it currently does not offer open access, the accessibility to its impactful content is essential for students, professionals, and researchers invested in these critical scientific disciplines.

CURRENT DRUG TARGETS is a leading peer-reviewed journal dedicated to advancements in the fields of Clinical Biochemistry, Drug Discovery, Molecular Medicine, and Pharmacology. Published by Bentham Science Publishers Ltd, this esteemed journal has solidified its position in the academic community with a 2023 Q2 ranking in several categories, highlighting its influence and relevance in drug research and development. With an ISSN of 1389-4501 and E-ISSN 1873-5592, CURRENT DRUG TARGETS facilitates the dissemination of high-quality articles that explore novel therapeutic strategies and drug design principles. Catered to researchers, professionals, and students, the journal has a commitment to advancing knowledge while addressing contemporary challenges in pharmacological sciences. As it converges from 2000 to 2024, CURRENT DRUG TARGETS remains a vital resource in understanding the complexities of drug action and interaction, making it indispensable for anyone pursuing cutting-edge research in related disciplines.

BIOORGANIC & MEDICINAL CHEMISTRY, published by Pergamon-Elsevier Science Ltd, is a prominent journal in the fields of biochemical research and drug discovery, with an ISSN of 0968-0896 and an E-ISSN of 1464-3391. Established in 1993, it has garnered respect and recognition, evidenced by its categorization in various quartile ranks across 2023, including Q2 in Clinical Biochemistry and Pharmaceutical Science. It holds significant Scopus rankings, placing it in the 75th percentile in Pharmaceutical Science and 74th percentile in Organic Chemistry, highlighting its influential contributions to ongoing research and developments. This journal provides a platform for disseminating advancements in bioorganic and medicinal chemistry, focusing on innovative methodologies, therapeutic advancements, and molecular pharmacology. Although it does not follow an open-access model, it remains a key resource for researchers, professionals, and students aiming to stay at the forefront of scientific discovery in the UK and beyond. The journal’s commitment to enhancing knowledge within the biomedical community makes it an essential read for those passionate about this dynamic field.